FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Isosorbide Mononitrate Extended-Release Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Par Pharmaceutical (New 04/19/2019)

Company Contact Information:
800-828-9393

Presentation Posting Date Related Information
30 mg, bottle of 100 (NDC 0603-4110-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
30 mg, bottle of 500 (NDC 0603-4110-28) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
30 mg, bottle of 1000 (NDC 0603-4110-32) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
60 mg, bottle of 100 (NDC 0603-4111-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
60 mg, bottle of 500 (NDC 0603-4111-28) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
60 mg, bottle of 1000 (NDC 0603-4111-32) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
120 mg, bottle of 100 (NDC 0603-4112-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English